According to our (Global Info Research) latest study, the global Aminocaproic Acid API market size was valued at US$ 66.98 million in 2025 and is forecast to a readjusted size of US$ 82.45 million by 2032 with a CAGR of 3.0% during review period.
Aminocaproic acid API is a key intermediate used in the production of antifibrinolytic drug formulations such as injections, oral solutions, and tablets. As an active pharmaceutical ingredient, it works by inhibiting fibrinolysis to achieve hemostatic effects. The API must meet strict pharmacopeial standards, including high purity, controlled impurity levels, moisture content, and low residual metals, to ensure the safety and efficacy of finished products. It is primarily manufactured by GMP-compliant facilities in countries like China and India, and widely exported to global pharmaceutical companies for use in hospital therapies and emergency clinical care.
As a well-established antifibrinolytic active pharmaceutical ingredient, aminocaproic acid API is widely used across the globe. The market is primarily driven by the production of generic formulations, including injections and oral preparations, for controlling bleeding in surgical, hematologic, obstetric, and urologic applications. With a mature synthesis process and stable production costs, countries such as China and India have become leading global suppliers, exporting extensively to regions like North America, Southeast Asia, and the Middle East. In response to tightening global regulations, including drug master file (DMF) registration and generic drug consistency evaluations, buyers are placing increasing emphasis on supplier qualifications, quality systems, and regulatory compliance.The aminocaproic acid API market is expected to exhibit stable and incremental growth in the coming years. Global aging demographics and the rising volume of surgeries will increase clinical demand for antifibrinolytic agents. Meanwhile, Asian manufacturers are poised to further expand their market share, leveraging cost advantages and complete supply chains. A growing number of producers are also shifting towards higher-value segments by developing sterile-grade APIs for injections, pursuing entry into regulated markets such as the U.S., Europe, and Japan, and upgrading production technologies with green chemistry and continuous processing. Market consolidation is likely, with leading GMP-compliant firms that hold DMFs/CEPs and have international audit experience capturing greater market share.The key drivers of this market include stable clinical demand, expanding surgical applications, rising awareness of antifibrinolytic therapy, clearer international regulatory pathways, and increasing global procurement of APIs. Additionally, government policies in several countries encourage the use of generics to reduce healthcare costs, which reinforces demand for cost-effective APIs. However, the sector also faces several constraints: intense price competition, concerns over thrombotic risks leading to usage restrictions in some regions, tightening environmental regulations that raise compliance costs, and the lack of international registration capabilities among small manufacturers. These challenges highlight the need for sustained investment in technology, quality, and regulatory alignment to ensure long-term, sustainable market growth.
This report is a detailed and comprehensive analysis for global Aminocaproic Acid API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Aminocaproic Acid API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Aminocaproic Acid API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Aminocaproic Acid API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Aminocaproic Acid API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Aminocaproic Acid API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Aminocaproic Acid API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biophore, Dipharma, Optimus Pharma, MSN Laboratories, Sekisui Medical, Sunny Pharmtech, Hunan Er-Kang Pharmaceutical, Changzhou Lanling Pharmaceutical, Jiangsu Yongan Pharmceutical, Sichuan Renan Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Aminocaproic Acid API market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Sterile
Non-sterile
Market segment by Application
Injection
Tablet
Oral Solutions
Other
Major players covered
Biophore
Dipharma
Optimus Pharma
MSN Laboratories
Sekisui Medical
Sunny Pharmtech
Hunan Er-Kang Pharmaceutical
Changzhou Lanling Pharmaceutical
Jiangsu Yongan Pharmceutical
Sichuan Renan Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Aminocaproic Acid API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Aminocaproic Acid API, with price, sales quantity, revenue, and global market share of Aminocaproic Acid API from 2021 to 2026.
Chapter 3, the Aminocaproic Acid API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Aminocaproic Acid API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Aminocaproic Acid API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Aminocaproic Acid API.
Chapter 14 and 15, to describe Aminocaproic Acid API sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Aminocaproic Acid API. Industry analysis & Market Report on Aminocaproic Acid API is a syndicated market report, published as Global Aminocaproic Acid API Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Aminocaproic Acid API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.